Biorepositories for NCI-Sponsored Cancer Clinical Trials

Policy Statement


The respective bank personnel of the CGB make every effort to ensure that there is an equitable distribution of biospecimens from the CGB. Appropriate and efficient use of the CGB resources is vital to promote the scientific mission supporting the collection and is the motivation for the efforts of the CGB to create a harmonized process for specimen inventorying and streamlining access to specimens.

Specific questions about the CGB program may be directed to Irina Lubensky, M.D., NCI Program Director, Cancer Diagnosis Program at (301) 496-7147.